ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

Feinstein Reintroduces New National Cancer Act

June 13, 2003

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

NCI RFA: Tobacco Use Research Centers

December 18, 1998

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009